SCOPE: Observational Study of the Consequences of the Protease Inhibitor Era
NCT00187512 is an observational study sponsored by University of California, San Francisco. As of 21 Nov 2026, it is recruiting participants. It studies HIV Infections. The registry lists an enrollment of 2,500 participants at 1 site in 1 country. The registry lists a start date of 31 Mar 2000 and a primary completion date of 31 Dec 2032. One of its registered investigators has a FindMyKOL profile.
Key facts
Registry attributes as recorded on the ClinicalTrials.gov study record.
| Field | Value |
|---|---|
| Registry ID | NCT00187512 |
| Status | Recruiting |
| Study type | Observational study |
| Lead sponsor | University of California, San Francisco |
| Enrollment | 2,500 |
| Registered sites | 1 |
| Countries | 1 |
| Conditions | HIV Infections |
| Start | 31 Mar 2000 |
| Primary completion | 31 Dec 2032 |
| Study completion | 31 Dec 2033 |
| Last update posted | 8 Sept 2026 |
Registered summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Recruiting
United States, by state
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Questions about NCT00187512
Each answer restates registry values shown on this page.
What is NCT00187512?
NCT00187512 is an observational study sponsored by University of California, San Francisco. It studies HIV Infections.
Is NCT00187512 recruiting?
As of 21 Nov 2026, it is recruiting participants. 1 of its 1 sites list their own status as recruiting.
Who leads NCT00187512?
The registry names Steven G. Deeks, M.D. (principal investigator, University of California, San Francisco) as the overall official.
Where does NCT00187512 run?
The registry lists 1 site in 1 country. Every site with a stated country is in one country: United States.
When is NCT00187512 expected to complete?
The registry lists a primary completion date of 31 Dec 2032 and a study completion date of 31 Dec 2033. The sponsor last updated the record on 8 Sept 2026.
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 21 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.